跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,982 条关于
“ALK gene”
全部
15,982
临床试验
8,103
药物
2,250
机构
133
资讯
5,496
4个月前
Chugai's Alecensa Receives World's First Tumor-Agnostic Approval for ALK Fusion-Positive Solid Tumors
去年
Ascentage Pharma's APG-2449 Advances to Phase III Trials for NSCLC Treatment
9年前
FDA Approves Fourth ALK Inhibitor for Lung Cancer
12年前
Evolving Landscape of Oncology Clinical Trials: Expert Insights on Precision Medicine and Patient Recruitment
去年
Nuvalent to Present First Clinical Data for Next-Generation ALK Inhibitor NVL-655 at AACR-NCI-EORTC Symposium
5个月前
Xuanzhu Biopharma's DiLuoAke Demonstrates Superior Efficacy Over Crizotinib in Phase III ALK-Positive NSCLC Trial
去年
CHMP Recommends Repotrectinib for ROS1+ NSCLC and NTRK+ Solid Tumors in Europe
上个月
Risk-Adapted Frameworks Reshape Pediatric Neuroblastoma Care, New Review Shows
去年
Alectinib Plus Bevacizumab Shows Promising Results in First-Line Treatment of ALK-Positive NSCLC
去年
ROSALINE Trial: Neoadjuvant Letrozole/Entrectinib Shows Limited Efficacy in Invasive Lobular Breast Cancer
第 1 页,共 550 页
上一页
下一页